High Flow Nasal Cannula as a Treatment for Obstructive Sleep Apnea
NCT ID: NCT03017859
Last Updated: 2017-01-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2017-01-31
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
High Flow Nasal Cannula for Obstructive Sleep Apnea
NCT03843372
Effect of High Flow Nasal Cannula Versus Continues Positive Airway Pressure in Adults With Obstructive Sleep Apnea
NCT05475119
An Investigation to Test the Efficacy of the High Flow (HF) Continuous Positive Airway Pressure (CPAP) in Patients With Obstructive Sleep Apnea (OSA)
NCT01025440
Clinical Efficacy of High-flow Nasal Cannula Oxygen Therapy in Patients With Obstructive Sleep Apnea
NCT05549245
Long-term Effect of High Flow Nasal Canula Therapy on Obstructive Sleep Apnea
NCT05549310
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High flow nasal cannula treatment
Airvo 2 device will be used to administer high flow air during the night
High flow nasal cannula
We shall use the Airvo 2 device to administer humidified and warmed air at high flow during sleep.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High flow nasal cannula
We shall use the Airvo 2 device to administer humidified and warmed air at high flow during sleep.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Confirmed diagnosis of obstructive sleep apnea, diagnosed at RMC sleep lab in the past 2 years
* Apnea Hypopnea Index (AHI)≥15
* Patient has difficulties to adjust or comply with CPAP treatment
* Signed Informed Consent Form
Exclusion Criteria
* Known carbon dioxide (CO2) retainers
* Weight change\>10% compared to time of OSA diagnosis
* Clinically unstable patients
* Pregnant women or special populations (e.g. children or patients unable to give informed consent)
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rabin Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mordechai Kremer
Head of Pulmonary Institute
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mordechai R Kramer, MD
Role: PRINCIPAL_INVESTIGATOR
Pulmonary Institute, Rabin Medical Center, Israel
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RMC-16-0152
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.